Homes for Sale in East Bay (San Francisco Bay Area)
Real Estate: Danville homes, Alameda County homes, Contra Costa County homes, Concord homes, Walnut Creek homes, Livermore, East Bay homes, Berkeley, San Ramon Danville Alamo homes, Pleasanton homes, Hayward homes, Orinda Moraga Lafayette homes, Walnut Creek Concord Pleasant Hill homes, Dublin homes, Orinda homes, Moraga homes, Lafayette homes, Antioch, Castro Valley homes, San Ramon homes, San Leandro, Pleasant Hill homes, San Lorenzo, Clayton, Alamo homes

World News   USA   Bay Area   Business   Bio Tech   Earnings, Bio Tech
Bay Area Earnings, Bio Tech Timeline Saturday, October 11     Author
Search Bay Area News Atlas:
Big 3rd Quarter Gains  Genentech Inc. reported a 56% surge in 3rd-quarter net income, fueled by drug sales of its colon cancer drug Chiron shares head upward  Investors hope that Novartis will boost a $4.5 billion purchase offer that the biotechnology firm turned down Chiron's earnings hit hard  The losses from the back-to-back failures of 2 flu vaccine manufacturing plants eroded profits Profits Soar 73% in 2Q
World News World Bio Tech (14) USA (204) Bay Area Bay Area Bio Tech (91) Business (1016) Bio Tech (91) Earnings, Bio Tech Earnings, Bio Tech on Wikipedia Earnings, Bio Tech on Web Earnings, Bio Tech Books
Real Estate
3Q Profit Up 21 % On Cancer Drug Sales  The profit rose nearly 21% from a year ago, beating expectations by a penny thanks to stronger-than-expected sales of the Avastin Genetech Slips After Stroke Warning  The company warned a group of eye specialists about an increased risk of stroke in elderly patients taking its drug McKesson's 3rd Qtr. Profit Rises 26%  3rd-quarter profit beat analyst expectations, after the drug distributor’s stock price shot to a new 52-week high 2Q Profit Soars to $531 Million  The biotechnology company blew past Wall Street expectations with a 79% surge in second quarter earnings Profit climbs by 48% in first quarter  Genentech Inc. raised its full-year earnings growth estimate to as much as 55% over 2005 Up 64% in quarter after good year  Earnings per share grew 63 percent to 31 cents as cancer drugs continued to build sales Problems Cause Chiron To Miss Earnings
4Q Profit Rises 6 Percent
Jan.14   Genentech
  The biotech giant barely scraped past expectations as stock dropped in after-hours trading as sales of a key product also fell below expectations


year 2007 Top ^

Oct.16   Genentech
Jan.26   Genetech
Jan.25   San Francisco


year 2006 Top ^

Jul.11   Genentech
Apr.12   Genentech
Jan.11   Genentech


year 2005 Top ^

Oct.18   Emeryville
  Chiron Corp. won't ship as many flu shots as it initially had hoped
Oct.10   Genentech
Sep.7   Emeryville
Jul.28   Emeryville
Jul.11   Genentech
  The second quarter profit is fueled by continued strong drug sales. The results exceeded the estimate by 4 cents
May.24   Genentech Genentech up on drug data  Drug for a eye disease showed that it may stabilize or reverse the condition in a clinical trial Apr.28   Emeryville Flu shot problem hurts Chiron's profit  1st-quarter results fell well short of analysts' expectations Apr.12   Genentech Biotech giant's profit up 61%  The colon cancer drug Avastin and other cancer drugs boost sales Jan.26   Emeryville Chiron's 2004 income falls dramatically
  Chiron hobbled by its failure to deliver half the nation's flu vaccine last year. It missed analysts' expectations
Jan.10   Genentech Profit surges, misses expectations by 1c  Biotechnology titan reported a 63% surge in its fourth-quarter profits on strong sales of a string of new drugs

year 2004 Top ^

Oct.20   Emeryville Flu Vaccine Fiasco Costs Chiron Millions  Vaccine fiasco will cost the company $91 million Oct.6   Genentech Profits surge on drug sales  Genentech reported a 52% surge in 3rd-quarter net income, fueled by strong drug sales across its product line Oct.5   Emeryville Flu maker Chiron slashes profit outlook
  Chiron cut its profit forecast by more than half after British officials pulled the company's license
Apr.7   Genentech Profits surge on brisk cancer drug sales  Biotechnology company yearlong hot streak continued when it reported robust profits for the first quarter Jan.14   Genentech Profits surge on strong drug sales  The results, lifted by popular cancer-fighting drugs, beat analysts' expectations

year 2003 Top ^

Oct.8   Genentech Biotech titan posts higher profits  Genentech is boosted by continued strong sales of its 2 blockbuster cancer-fighting drugs and a one-time legal settlement Jun.10   Menlo Park Geron's stock soars on patent grant Mar.18   Menlo Park Geron's stock soars on research news Mar.13   Brisbane VaxGen stock soars on forecast Jan.15   Genentech Reports continued strong earnings

year 2002 Top ^

Nov.7   South SF CEO cashes in while shareholders lose
Apr.5   Genentech Stock falls Jan.16   Genentech Earnings rise

year 2001 Top ^



World Earnings News Timeline

Add a favorite (file a bookmark) to Earnings, Bio Tech News Timeline

Please send feedback to: support@mapreport.com

Advertise on Earnings, Bio Tech Page